EN
Türkçe
Deutsch
Français
Español
Português
Русский
العربية
中文
日本語
Moderna (MRNA)
Moderna last traded at 207.97 USD. Over the past month the price moved +5.42%. Historical scenarios, expert targets and the plain-language read from AIsier.
One-year price chart
Last price
207.97 USD
- 1 week
- -14.09%
- 1 month
- +5.42%
- 3 months
- +281.67%
- 1 year
- +680.08%
- 52-week high
- 245.81 USD
- 52-week low
- 22.36 USD
Stocks
- Symbol
- MRNA
- Currency
- USD
- Exchange
- US
- Market value (USD)
- 79,887,106,048 USD ()
AIsier's plain-language read
Moderna lost about a tenth of its value in just one week.
What is going on right now?
The stock dropped roughly 12% over the past seven days, giving back a chunk of the nearly 40% climb it had over the prior month.
How is the business itself doing?
Moderna makes vaccines and therapies using mRNA technology, with Spikevax as its main product. Right now the company spends far more than it brings in: for every dollar of sales, costs are significantly higher, so it is running at a deep loss.
What stands out?
Despite those losses, Moderna carries very little debt and generated about $299 million in cash over the past year. That cash cushion is what keeps the lights on while it develops new products for RSV, flu, cancer, and HIV.
What comes next?
Moderna's next earnings report is due November 6, the first look at whether newer products like its RSV vaccine are starting to pull their weight.
FAQ
What is the current price of Moderna?
As of Oct. 27, 2026, the latest recorded price of Moderna (MRNA) was 207.97 USD.
How has Moderna moved recently?
Measured from closing prices: -14.09% over one week, +5.42% over one month and +680.08% over one year.